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httpcense.Summary Introduction: Thromboembolic complications associated with infection by Mycobacte-
rium tuberculosis have been reported in the literature that occurred in 1.5–3.4% of TB infection,
which is a risk factor for deep vein thrombosis (DVT) related to the hypercoagulable state second-
ary to the inﬂammatory state.
Objective: We report in this study the pathophysiological, therapeutic, epidemiological, and clin-
ical aspects, of this association.
Methods: This is a retrospective study done in our department between January 2010 and May
2013. It is about 30 cases of conﬁrmed pulmonary tuberculosis associated with deep vein thrombosis.
Results: It is about 21 men and 9 women. Pulmonary tuberculosis was conﬁrmed by the presence
of acidoalcoolo-resistant bacillus on the sputum on a direct examination of 25 cases and bronchial
aspiration in 5 cases. All patients had extensive radiological lesions. Phlebitis occurred within a mean
of 17 days after the diagnosis of tuberculosis. It was conﬁrmed by venous doppler deep ultrasound of
inferior membres. All patients received anti-tuberculosis drugs in association with anticoagulant
treatment.
Etiologic investigations showed positive anti-phospholipid antibodies in one case, and decrease in
C and S proteins in 2 patients in which phlebitis was complicated by arterial pulmonary embolism.
We had difﬁculties in controlling prothrombin level in 9 cases and we prescribed low molecular
weight heparin for 6 months in two cases.
Conclusion: Thromboembolic disease is diagnosed systematically in the TB patients because of
the risk of this complication particularly in extensive and severe forms. Prophylactic anticoagulation
ﬁnds its indications in these forms.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
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Active pulmonary tuberculosis may be complicated by
deep vein thrombosis associated with a hypercoagulable
state secondary to the hypercoagulable state secondary
to the inﬂammatory state. Vascular complications associ-
ated with infection by Mycobacterium tuberculosis have
been reported in the literature occurred in 1.5–3.4% of
TB infection [1,2].
Patients and methods
This is a retrospective study done in our department between
January 2010 and May 2013. It is about 30 cases of con-
ﬁrmed pulmonary tuberculosis associated with deep vein
thrombosis.Results
It is about 21 men and 9 women. The mean age was 45 years.
Ten patients had a history of pulmonary tuberculosis. In the
current episode, pulmonary tuberculosis was conﬁrmed by
the presence of acidoalcoolo-resistant bacillus on the sputum
at direct examin 25 cases (83.3%) and the ﬁbro-aspiration in
ﬁve cases (16.7%). It is 25 cases of pulmonary tuberculosis,
including 4 cases of complicated pyopneumothorax, and 5
cases of miliary. The chest radiograph showed extensive lung
lesions in all patients with bilateral lesions in 12 cases (40%).
All patients receiving isoniazid, rifampicin, pyrazinamide and
ethambutol Phlebitis occurred within a mean of 17 days after
the diagnosis of tuberculosis.
It was revealed by clinical signs and high plasma D-dimer
and was conﬁrmed by venous doppler deep ultrasound of
inferior membres. In 5 cases of phlebitis was complicated by
pulmonary embolism. No patient had suggestive of Behcet dis-
ease or signs of systemic disease. Etiologic investigations
showed the presence of antiphospholipid antibodies in a pa-
tient and protein S deﬁciency and C in 2 patients. The oral
anticoagulants (vitamin K antagonists) were associated with
low molecular weight heparins (LMWH) hanging ﬁve days
on average, they are arrested after monitoring prothrombin
which is corrected within 15 days on average. We had difﬁcul-
ties for controlling prothrombin level in 9 cases and we must
prescribe low molecular weight heparin for 6 months in two
case. In 25 cases, the oral anticoagulation was stopped after
3 months, while in 3 cases, this treatment was extended beyond
3 months. We noted good clinical, bacteriological and radio-
logical progression after 6 months of TB treatment.Discussion
Our cases show that VTE may complicate severe pulmonary
tuberculosis and that these events occur at presentation or la-
ter in the course of the disease. Robson et al., found 35 patients
with pulmonary TB and DVT. In 33 of them, DVT occurred
7 days after the diagnosis of TB, while only in two, DVT
was the presenting feature [3]. Other reports also demonstrate
that thrombotic phenomena in patients with pulmonary TB
occur in other sites. These may include hepatic veins [4], the
vena porta, [5], the inferior vena cava [6], cerebral venous si-
nuses [7,8], and the central retinal vein [9] which reinforces
the link between these conditions. Disseminated TB may in-
duce at the peripheral blood the activation of mononuclear
cells, and the interaction of these cells activated with mycobac-
terial products induces increased synthesis of factor tumor
necrosis alpha and interleukin-6 [10–12].
TB has several mechanisms that can induce a hypercoagu-
lable state may lead to thromboembolic complications. Vari-
ous studies have concluded that the high level of plasma
ﬁbrinogen, impaired ﬁbrinolysis associated with a decrease in
antithrombin III, protein C and platelet aggregation appear
to induce a hypercoagulable state promoting the development
of deep vein thrombosis pulmonary tuberculosis [1,3,13].
Some authors have mentioned the high incidence of anti-
phospholipid antibodies detected in tuberculosis, and the pos-
sible relationship between these and protein S. Although
studies on the activity of prothrombin in tuberculosis are not
numerous, it seems that hypoprothrombinaemia that rather
hyperactivity of prothrombin exists in appreciable number of
cases. Various studies indicate that prothrombin deﬁciency oc-
curs in approximately one third of TB patients [1,14,15].
Cytokines by their pro-inﬂammatory character, will acti-
vate the vascular intima and make thrombogenic endothelium.
They will also lead to a stimulation of hepatic synthesis of
coagulation proteins [10,16]. These risks of hypercoagulability
are increased by the immobility and bedrest because of the
morbidity caused by the disease.
However, thrombosis can also result from venous compres-
sion by lymph nodes in ganglionar forms of TB, as ret roperi-
toneal adenopathies may cause inferior vena cava thrombosis
in the absence of any haemostatic abnormalities [17].
These haemostatic changes improve during the ﬁrst month
of TB treatment [15] and for this reason, it should be immedi-
ately started in addition to anticoagulant therapy. Frequently,
a higher dose of warfarin is necessary to achieve therapeutic
INR levels, because of rifampin effects on cytochrome P450
[18]. Additionally, this drug may also contribute to the hyper-
coagulable state by decreasing production and increasing
Association deep veinous thrombosis with pulmonary tuberculosis 543clearance of anticoagulant hepatic proteins. Consequently, the
initial phase of treatment may result in a higher risk for devel-
opment of DVT [19,20].
Conclusion
Thromboembolic disease is to search systematically at the TB
view of the risk of occurrence of this complication particularly
in extensive and severe forms. Prophylactic anticoagulation
ﬁnd its indications in these forms.
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